Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eccles

Showing results (141-150 of 269) with videos related to

Pageof 27
Sort By:
Oncotarget|November 5, 2013
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAXMarissa V Powers, Melanie Valenti, Susana Miranda, et al.
Scientific Reports|February 22, 2020
A semi-automated technique for adenoma quantification in the Apc<sup>Min</sup> mouse using FeatureCounterAmy L Shepherd, A Alexander T Smith, Kirsty A Wakelin, et al.
Magnetic Resonance in Medicine|September 1, 2010
Bayesian estimation of changes in transverse relaxation ratesSimon Walker-Samuel, Matthew Orton, Lesley D McPhail, et al.
Cancer Research|December 1, 1995
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methodsW J Smellie, C J Dean, N P Sacks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatinJames Witham, Melanie R Valenti, Alexis K De-Haven-Brandon, et al.
Molecular Cancer Therapeutics|May 12, 2010
Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastomaNathalie Gaspar, Swee Y Sharp, Suzanne A Eccles, et al.
Molecular Genetics & Genomic Medicine|April 1, 2017
Gene-centric analysis implicates nuclear encoded mitochondrial protein gene variants in migraine susceptibilityShani Stuart, Miles C Benton, David A Eccles, et al.
Nuclear Medicine and Biology|May 1, 1995
Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapyH Young, P Carnochan, M Trivedi, et al.
Neuropsychologia|August 12, 2015
Sensations of skin infestation linked to abnormal frontolimbic brain reactivity and differences in self-representationJ A Eccles, S N Garfinkel, N A Harrison, et al.
Cell Cycle (Georgetown, Tex.)|January 30, 2009
Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human gliomaSandrine Guillard, Paul A Clarke, Robert Te Poele, et al.
Pageof 27

Showing results (141-150 of 269) with videos related to

Sort By:
Pageof 27
Oncotarget|November 5, 2013
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAXMarissa V Powers, Melanie Valenti, Susana Miranda, et al.
Scientific Reports|February 22, 2020
A semi-automated technique for adenoma quantification in the Apc<sup>Min</sup> mouse using FeatureCounterAmy L Shepherd, A Alexander T Smith, Kirsty A Wakelin, et al.
Magnetic Resonance in Medicine|September 1, 2010
Bayesian estimation of changes in transverse relaxation ratesSimon Walker-Samuel, Matthew Orton, Lesley D McPhail, et al.
Cancer Research|December 1, 1995
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methodsW J Smellie, C J Dean, N P Sacks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatinJames Witham, Melanie R Valenti, Alexis K De-Haven-Brandon, et al.
Molecular Cancer Therapeutics|May 12, 2010
Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastomaNathalie Gaspar, Swee Y Sharp, Suzanne A Eccles, et al.
Molecular Genetics & Genomic Medicine|April 1, 2017
Gene-centric analysis implicates nuclear encoded mitochondrial protein gene variants in migraine susceptibilityShani Stuart, Miles C Benton, David A Eccles, et al.
Nuclear Medicine and Biology|May 1, 1995
Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapyH Young, P Carnochan, M Trivedi, et al.
Neuropsychologia|August 12, 2015
Sensations of skin infestation linked to abnormal frontolimbic brain reactivity and differences in self-representationJ A Eccles, S N Garfinkel, N A Harrison, et al.
Cell Cycle (Georgetown, Tex.)|January 30, 2009
Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human gliomaSandrine Guillard, Paul A Clarke, Robert Te Poele, et al.
Pageof 27